Exforge HCT (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Exforge HCT drug offered from Novartis Pharmaceuticals Corporation. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | amlodipine valsartan and hydrochlorothiazide |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; VALSARTAN; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-04-04 |
| END MARKETING DATE: | 0000-00-00 |
Exforge HCT HUMAN PRESCRIPTION DRUG Details:
| Item Description | Exforge HCT from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 160; 12.5(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2009-04-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0559_ccf620d2-43b0-4631-9a2a-3cb07693c5b6 |
| PRODUCT NDC: | 0078-0559 |
| APPLICATION NUMBER: | NDA022314 |
Other AMLODIPINE BESYLATE; VALSARTAN; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
| Manufacturer / Labeler | Proprietary Name |
| LUPIN LIMITED | Amlodipine, Valsartan and Hydrochlorothiazide |
| Lupin Pharmaceuticals, Inc. | Amlodipine, Valsartan and Hydrochlorothiazide |
| Novartis Pharmaceuticals Corporation | Exforge HCT |
| Par Pharmaceutical, Inc. | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE |
| Physicians Total Care, Inc. | Exforge HCT |
| Sandoz Inc | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE |
| Teva Pharmaceuticals USA, Inc. | Amlodipine, Valsartan, and Hydrochlorothiazide |
| Torrent Pharmaceuticals Limited | Amlodipine, Valsartan and Hydrochlorothiazide |
